| Code | CSB-MP890933HU |
| Abbreviation | Recombinant Human ZNRF3 protein, partial (Active) |
| MSDS | |
| Size | $190 |
| Order now | |
| Image | |
| Have Questions? | Leave a Message or Start an on-line Chat |
ZNRF3 functions as a critical negative regulator of Wnt signaling by targeting Frizzled receptors for ubiquitin-dependent degradation, making it a key node for studying Wnt pathway modulation. This recombinant human ZNRF3 partial construct (aa 56–219), expressed in mammalian cells with a C-terminal 6xHis tag, demonstrates confirmed binding to human RSPO2 with an EC50 of 5.091–6.991 ng/mL in functional ELISA, supporting its use as a positive control in ligand-binding assays, inhibitor screening for IC50 determination, and R-spondin interaction studies. The tag placement at the C-terminus preserves the extracellular domain architecture required for accurate kinetic parameter analysis and substrate specificity profiling. With purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg, this preparation meets the quality thresholds commonly required for cell-based Wnt signaling assays and drug candidate evaluation targeting the ZNRF3–RSPO interaction axis.
There are currently no reviews for this product.